Parameters | ||
Name | Nominal or Starting Value | Approximate Biological Correlate |
 M | 20.8 (rat) | Relative nutrient and toxin delivery/absorption rate in the liver |
 G | 3.5x10−4 (rat) | Growth rate of hepatocyte mass [mass equivalent doublings/min] |
 kIL6 | 1.5 | Rate at which non-parenchymal cells (primarily Kupffer cells) are able to modify the cytokine milieu post-PHx |
 κIL6 | 0.9 | Rate of cytokine degradation |
 VJAK | 2x104 | Maximum JAK activation rate |
 Km JAK | 104 | JAK Michaelis concentration |
 κJAK | 0.4 | Rate of JAK degradation |
 [STAT3] | 2 | Relative concentration of monomeric STAT3 in the liver |
 VSTAT3 | 7.5x102 | Maximum STAT3 phosphorylation rate |
 Km STAT3 | 0.4 | pSTAT3 Michaelis concentration |
 κSTAT3 | 0.1 | Rate of pSTAT3 dephosphorylation |
 VSOCS3 | 2.4x104 | Maximum SOCS3 activation rate |
 Km SOCS3 | 7x10−4 | SOCS3 Michaelis concentration |
 κSOCS3 | 0.4 | Rate of SOCS3 degradation |
 KI SOCS3 | 1.5x10−2 | SOCS3 Inhibition effect on STAT3 phosphorylation |
 VIE | 2.5x102 | Maximum IE gene activation rate |
 Km IE | 18 | IE gene Michaelis concentration |
 κIE | 5 | Rate of IE gene degradation |
 κDEG | 7 | Rate of ECM degradation by MMPs |
 κECM | 33 | Rate of constitutive ECM degradation |
 kGF | 0.113 | Rate at which non-parenchymal cells (primarily hepatic stellate cells) directly & indirectly produce growth factors post-PHx |
 κGF | 0.23 | Rate of growth factor degradation |
 kup | 6x10−2 | Rate of growth factor absorption/binding to the ECM |
 kQ | 7x10−3 | Maximum rate of hepatocyte transition from Quiescence to Primed [cells/min] |
 kP | 4.4x10−3 | Maximum rate of hepatocyte transition from Primed to Replicating [cells/min] |
 kR | 5.4x10−3 | Maximum rate of hepatocyte transition from Replicating to Quiescence [cells/min] |
 kprol | 2x10−2 | Rate of hepatocyte progression through the cell cycle [doublings/min] |
 kreq | 0.1 | Requiescence rate of Primed hepatocytes [cells/min] |
 θreq | 8 | None |
 βreq | 3 | None |
 kap | 0.1 | Apoptosis rate of damaged hepatocytes |
 θap | 9x10−3 | None |
 βap | 4.5x10−3 | None |
 kMBF | 1 | Rate of release of matrix bound factors during ECM remodeling |
 κMBF | 1 | Degradation rate of matrix bound factors once they are released from the ECM |
Variables | ||
Name | Nominal or Starting Value | Approximate Biological Correlate |
 Q | 1 | Fraction of hepatocytes in the Quiescent state |
 P | 0 | Fraction of hepatocytes in the Primed state |
 R | 0 | Fraction of hepatocytes in the Replicating state |
 [IL-6] | 1 | Cytokine microenvironment of the liver |
 [JAK] | 1 | Relative levels of activated receptors for cytokine signals in hepatocytes |
 [pSTAT3] | 1 | Relative levels of phosphorylated STAT-3 compared to monomeric STAT-3 or other downstream effectors of cytokine signaling (i.e. NF-κB) |
 [SOCS3] | 1 | Relative levels of SOCS3 or other inhibitors of cytokine signaling |
 [IE] | 1 | Relative levels of immediate early genes induced in hepatocytes (e.g. cFOS, cJUN, and AP-1) |
 [GF] | 1 | Relative bioavailability of growth factors promoting hepatocyte proliferation |
 [ECM] | 1 | Relative levels of extracellular matrix buildup of matrix composed of collagens inhibitory to regeneration |
 [MBFECM] | 50 | Relative levels of matrix bound factors priming hepatocytes |
 [MBFFree] | 0 | Relative levels of free matrix bound factors that were initially bound by ECM |